From the Guidelines
The next step in managing a patient with severe anemia and a normal CT abdomen pelvis with IV contrast is to initiate iron replacement therapy, as iron deficiency is the most common cause of anemia, and a normal CT scan does not rule out gastrointestinal blood loss or poor iron absorption. According to the American Gastroenterological Association (AGA) guideline 1, ferritin is the most commonly used marker for diagnosing iron deficiency, and a cut-off value of 45 mg/dL is recommended for individuals with anemia.
In patients with severe anemia, oral iron supplementation is usually initiated first, but IV iron may be given initially in some cases, especially if oral iron is not well tolerated or absorbed 1. The goal of iron repletion is to improve quality of life and decrease the risk of complications related to anemia.
Key considerations in the management of severe anemia include:
- Evaluating dietary iron intake and reviewing menstrual blood losses in premenopausal women
- Searching for gastrointestinal conditions leading to poor iron absorption or blood loss, including Helicobacter pylori infection
- Considering multidisciplinary management, including gastroenterologists, hematologists, and nutritionists, in complex cases
- Initiating iron replacement therapy, either orally or intravenously, depending on the patient's condition and tolerance 1.
It is essential to recognize that patients with inflammatory conditions may have iron deficiency or iron-deficiency anemia in the setting of a ferritin level greater than 45 mg/dL, and confirmatory testing with transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin equivalent may be helpful in these situations 1.
From the FDA Drug Label
Purpose Iron Supplement Therapy Ferrous Sulphate is an iron supplement for iron deficiency and iron deficiency anemia when the need for such therapy has been determined by a physician. The next step in managing a patient with severe anemia and a normal CT abdomen pelvis with IV contrast is to consider iron supplement therapy under the advice and supervision of a physician, as the CT scan does not indicate any acute abdominal or pelvic pathology that would require immediate intervention 2.
- The patient's severe anemia should be further evaluated to determine the underlying cause.
- Iron deficiency should be confirmed before initiating iron supplement therapy.
- If iron deficiency is confirmed, ferrous sulphate can be considered as an iron supplement 2.
From the Research
Next Steps in Managing Severe Anemia
- A normal CT abdomen pelvis with IV contrast does not rule out gastrointestinal bleeding, as some sources of bleeding may not be visible on CT scans 3, 4.
- The next step in managing a patient with severe anemia and a normal CT abdomen pelvis with IV contrast is to perform a stepwise evaluation to identify the cause of bleeding, which may include:
- Esophagogastroduodenoscopy (EGD) and colonoscopy, which can find the bleeding source in 48 to 71 percent of patients 3.
- Capsule endoscopy, which has a diagnostic yield of 61 to 74 percent if a cause is not found after EGD and colonoscopy 3.
- Deep enteroscopy, which can reach into the mid and distal small bowel to further investigate and treat lesions found during capsule endoscopy or computed tomographic enterography 3.
- Bidirectional endoscopy (gastroscopy and colonoscopy) is recommended as the initial diagnostic strategy for unexplained anemia with iron deficiency, except in premenopausal women < 40 years of age 5.
- Small intestine investigation (capsule endoscopy, CT, or MRI enterography) is not recommended routinely after negative bidirectional endoscopy but should be conducted if there are red flags indicating malignant or inflammatory small bowel disease 5.
- Iron supplementation should be administered to normalize hemoglobin levels and replenish iron stores, with oral treatment recommended as the first line of treatment 5.